Secondary Data Analysis for Cancer Prevention and Control

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with Unit

Memorial Deadline: Thursday 23rd, November 2017

External Deadline: Tuesday 28th, November 2017

Description

CIHR and other funding agencies have invested in the establishment of cohorts and databases. These cohorts and databases house high quality health systems and patient data sets and/or biospecimens. As such, there exists a wealth of information that has the potential to answer research questions that go beyond those for which the data or samples were originally collected.

Analyses of existing datasets and biospecimens are a cost-effective way to answer novel research questions and test innovative hypotheses with the potential for high-impact discoveries and timely translation to practice to improve patient experiences and outcomes.

This current opportunity will support the utilization of very large well-established accessible multi-jurisdictional cohorts, and administrative databases. Cohorts such as the Canadian Partnership for Tomorrow Project (CPTP) are of particular interest for this funding opportunity. Large international databases may also be used provided the analysis occurs in Canada. Personal data sets or data sets from a previous project would not be eligible. Accessible means that there is access to the data set for the cancer research community at large. There will be two funding streams; a first stream on breast cancer and a second stream on all other cancers.

Research Areas

This funding opportunity will support research that covers the breadth of cancer prevention and cancer control specific to the three following ICR Strategic Priorities:

Targeting High Fatality Cancers
Health Economics and Health Services Research in Cancer Control
Redressing Cancer Risk Factor Disparities and Prevention Service Inequities

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

The total amount available for this funding opportunity is $1,000,000 enough to fund approximately ten (10) grants. The initial amount per grant is $75,000 for up to 1 year.
Of this $1,000,000:
- $250,000 will be dedicated for a possible additional amount of up to $25,000 per grant for biologic sample analysis from the cohorts, for a maximum grant value of $100,000. The biological sample analysis may only occur with an existing repository and established database with sample data (not on newly collected samples). A justification will be required to have access to these additional funds.
- In considering the initial $750,000 for the 10 grants:
  - $150,000 is available to fund two (2) grants relevant to breast cancer.
  - $600,000 is available to fund eight (8) grants relevant to all other cancers.
- If there are no fundable applications in the breast cancer funding pool, the funds will be transferred to the other pool.

Visit CIHR’s website for additional funding details.